Impact of Surgical and Medical Castration on Serum Testosterone Level in Prostate Cancer Patients
Author(s) -
Giacomo Novara,
Antonio Galfano,
Silvia Secco,
Vincenzo Ficarra,
Walter Artibani
Publication year - 2009
Publication title -
urologia internationalis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.771
H-Index - 53
eISSN - 1423-0399
pISSN - 0042-1138
DOI - 10.1159/000209352
Subject(s) - medicine , castration , triptorelin , prostate cancer , goserelin , testosterone (patch) , androgen deprivation therapy , urology , orchiectomy , androgen , buserelin , oncology , endocrinology , cancer , hormone , agonist , gonadotropin releasing hormone , luteinizing hormone , receptor
The paper aims at evaluating the role of testosterone levels and their cut-off points in the treatment of prostate cancer with androgen deprivation therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom